WuXi Biologics (Cayman) Inc. Share Price
Equities
2269
KYG970081173
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.00 HKD | -0.59% |
|
+5.17% | +17.68% |
| 25/03 | WuXi Biologics Inc., 2025 Earnings Call, Mar 25, 2026 | |
| 24/03 | WuXi Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Capitalization | 13TCr 15TCr 1.95TCr 1.66TCr 1.53TCr 1.44TCr 2.69TCr 1,82000Cr 2.74TCr 18TCr 7.02TCr 87TCr 7.33TCr 7.18TCr 3,10400Cr | P/E ratio 2025 |
24.4x | P/E ratio 2026 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise value | 13TCr 15TCr 1.85TCr 1.57TCr 1.45TCr 1.37TCr 2.55TCr 1,72500Cr 2.6TCr 17TCr 6.66TCr 83TCr 6.95TCr 6.81TCr 2,94300Cr | EV / Sales 2025 |
4.82x | EV / Sales 2026 * | 4.86x |
| Free-Float |
86.37% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: WuXi Biologics (Cayman) Inc.
| 1 day | -0.59% | ||
| 1 week | +5.17% | ||
| Current month | +12.05% | ||
| 1 month | +6.14% | ||
| 3 months | -7.55% | ||
| 6 months | +2.95% | ||
| Current year | +17.68% |
| 1 week | 35.04 |  | 38.34 |
| 1 month | 30.94 | | 38.34 |
| Current year | 30.94 | | 44 |
| 1 year | 19.82 | | 44 |
| 3 years | 10.14 | | 55.15 |
| 5 years | 10.14 | | 148 |
| 10 years | 8.33 | | 148 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Sheng Chen
CEO | Chief Executive Officer | 54 | 01/01/2016 |
Ming Tu
DFI | Director of Finance/CFO | 56 | 23/08/2021 |
Xuejun Gu
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Ge Li
CHM | Chairman | 59 | 01/02/2014 |
Zhi Sheng Chen
BRD | Director/Board Member | 54 | 01/02/2014 |
Yan Ling Cao
BRD | Director/Board Member | 42 | 01/05/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -9.80% | 2.99% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.59% | +5.17% | +74.53% | -31.61% | 1.97TCr | |
| +1.25% | +6.23% | +34.42% | +102.16% | 5.17TCr | |
| +0.79% | +5.18% | +100.62% | +24.18% | 4.71TCr | |
| -0.02% | -5.91% | +115.97% | +815.82% | 3.31TCr | |
| +1.38% | +9.81% | -3.84% | -24.10% | 2.49TCr | |
| +0.72% | +3.69% | +43.43% | -36.16% | 1.79TCr | |
| +6.89% | +7.20% | +68.07% | +236.91% | 1.62TCr | |
| +3.88% | +8.48% | -20.21% | +1,228.03% | 1.62TCr | |
| +6.97% | +6.57% | +67.31% | - | 1.44TCr | |
| -0.69% | +2.56% | +62.88% | +118.94% | 1.2TCr | |
| Average | +2.15% | +2.84% | +54.32% | +270.46% | 2.53TCr | |
| Weighted average by Cap. | +1.64% | +3.48% | +59.29% | +237.41% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 2.2TCr 2.53TCr 322.4Cr 273.23Cr 251.68Cr 237.6Cr 443.62Cr 30TCr 451.66Cr 2.96TCr 1.16TCr 14TCr 1.21TCr 1.18TCr 51TCr | 2.52TCr 2.9TCr 370.04Cr 313.61Cr 288.87Cr 272.7Cr 509.18Cr 34TCr 518.4Cr 3.4TCr 1.33TCr 17TCr 1.39TCr 1.36TCr 59TCr |
| Net income | 452.78Cr 520.35Cr 66Cr 56Cr 52Cr 49Cr 91Cr 6.18TCr 93Cr 609.85Cr 238.66Cr 2.97TCr 249.29Cr 244.02Cr 11TCr | 543.77Cr 624.91Cr 80Cr 68Cr 62Cr 59Cr 109.78Cr 7.43TCr 111.77Cr 732.39Cr 286.61Cr 3.57TCr 299.38Cr 293.05Cr 13TCr |
| Net Debt | -690.45Cr -793.49Cr -101.3Cr -86Cr -79Cr -75Cr -139.4Cr -9.43TCr -141.92Cr -929.96Cr -363.93Cr -4.53TCr -380.14Cr -372.11Cr -16TCr | -1.07TCr -1.23TCr -156.88Cr -132.96Cr -122.47Cr -115.62Cr -215.88Cr -15TCr -219.78Cr -1.44TCr -563.6Cr -7.02TCr -588.7Cr -576.27Cr -25TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 37.00 $ | -0.59% | 2,25,47,474 |
| 14/26/14 | 37.22 $ | +5.50% | 2,71,89,230 |
| 13/26/13 | 35.28 $ | -1.73% | 1,47,45,620 |
| 10/26/10 | 35.90 $ | +1.01% | 1,94,14,230 |
| 09/26/09 | 35.54 $ | +1.02% | 2,21,97,190 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2269 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition